| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/13/2011 | US20110008385 Immunogenic composition |
| 01/13/2011 | US20110008383 Compositions of toll-like receptor agonists and malaria antigens and methods of use |
| 01/13/2011 | US20110008382 Compositions and methods using recombinant MHC molecules for the treatment of uveitis |
| 01/13/2011 | US20110008381 Suppression of allergic inflammation by ascaris heme-binding protein (hbp) |
| 01/13/2011 | US20110008378 Modified flagellin improved toll-like receptor 5 stimulating activity |
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008376 Immunogenic compositions capable of activating t-cells |
| 01/13/2011 | US20110008369 Pd-1 binding proteins |
| 01/13/2011 | US20110008368 Methods of modulating the ox40 receptor to treat cancer |
| 01/13/2011 | US20110008364 Antibodies to tgf-beta |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008356 Il-17 heteromeric receptor complex |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008352 Toll-Like Receptor 3 Antagonists |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008343 Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008335 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using NK Cell Potentiating Compounds |
| 01/13/2011 | US20110008332 Combination Therapy to Treat Persistent Viral Infections |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008329 Methods of Treating RSV Infections And Related Conditions |
| 01/13/2011 | US20110008326 Binding agents directed against il-4 receptor for the treatment of tumors, inflammatory and immunological disorders |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008318 Toll-like receptor 5 ligands and methods of use |
| 01/13/2011 | US20110008304 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
| 01/13/2011 | US20110008289 Hyperglycosylated polypeptide variants and methods of use |
| 01/13/2011 | US20110008286 Novel proline substituted cyclosporin analogues |
| 01/13/2011 | US20110008285 Novel cyclosporin analogues |
| 01/13/2011 | US20110008284 Novel clyclosporin analogues |
| 01/13/2011 | US20110008282 IL-1alpha immunization induces autoantibodies protective against atherosclerosis |
| 01/13/2011 | US20110008279 Methods and Compositions Relating to Adhesins as Adjuvants |
| 01/13/2011 | US20110008278 Modulators of paraptosis and related methods |
| 01/13/2011 | US20110008257 Inhibitors of bruton's tyrosine kinase |
| 01/13/2011 | US20110008251 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | CA2803282A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767392A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767288A1 Novel polymorphic form of teriflunomide salts |
| 01/13/2011 | CA2767079A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | CA2766737A1 Diagnosis and treatment of autoimmune demyelinating diseases |
| 01/12/2011 | EP2273419A1 Methods of treating and preventing colitis involving IL-13 and NK-T cells |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | EP2272844A1 Five-membered ring compound |
| 01/12/2011 | EP2272835A1 Novel five-membered ring compound |
| 01/12/2011 | EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP2272526A2 Adjuvant for transcutaneous immunization |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271645A1 Compounds and compositions as kinase inhibitors |
| 01/12/2011 | EP2271643A1 Compounds |
| 01/12/2011 | EP2271630A1 Compounds and compositions as protein kinase inhibitors |
| 01/12/2011 | EP2271363A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 01/12/2011 | EP2271333A2 Induction of proliferation, effector molecule expression, and cytolytic capacity of hiv-specific cd8+ t cells |
| 01/12/2011 | EP1865058B1 Anti-cd-20 monoclonal antibody |
| 01/12/2011 | EP1644034B1 Composition for enhancing an immune response comprising packaged virus-like particles |
| 01/12/2011 | EP1517907B1 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 01/12/2011 | EP1302541B1 Method for recognizing bacterial DNA |
| 01/12/2011 | EP1221972B1 Plant lectins as mucosal adjuvants |
| 01/12/2011 | EP1003782B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/12/2011 | CN201701512U Tablets capsule containing loratadine tablets and ambroxol hydrochloride tablets |
| 01/12/2011 | CN1985994B Improved enteric medicine composition with mycophenolate |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1893937B Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 01/12/2011 | CN1823771B FK506 oral medicinal composition |
| 01/12/2011 | CN1738595B Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/12/2011 | CN101945893A Anti-human nkg2d monoclonal antibodies and use thereof |
| 01/12/2011 | CN101945885A Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 01/12/2011 | CN101945865A 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases |
| 01/12/2011 | CN101945864A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 01/12/2011 | CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 01/12/2011 | CN101945862A Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 01/12/2011 | CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 01/12/2011 | CN101945668A Combination of an iron chelator and an immunosuppressant and use thereof |
| 01/12/2011 | CN101945666A Compositions and methods for treatment of autoimmune and allergic diseases |
| 01/12/2011 | CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/12/2011 | CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry |
| 01/12/2011 | CN101940768A Sheep placenta |
| 01/12/2011 | CN101940713A Medicinal liquor for improving body immunity and preparation method thereof |
| 01/12/2011 | CN101940694A Medicament for regulating sub-health of human body |
| 01/12/2011 | CN101940685A Face-beautifying health wine and preparation method thereof |
| 01/12/2011 | CN101940663A Beauty-maintaining and life-prolonging medicinal liquor and preparation method thereof |
| 01/12/2011 | CN101940619A Chinese medicinal preparation for treating guillain-barre syndrome (GBS) diseases and preparation method thereof |
| 01/12/2011 | CN101940613A Codonopsis pilosula and radix astragali oral solution as well as preparation method and application thereof on aspect of enhancing immunologic functions of livestock and poultry |
| 01/12/2011 | CN101940611A Plant source animal use immunopotentiator developed by cordyceps militaris fermented traditional Chinese medicine astragalus |
| 01/12/2011 | CN101940599A Liquid for preventing and treating human diseases |
| 01/12/2011 | CN101940538A Xenon-containing cosmetics and preparation method thereof |
| 01/12/2011 | CN101642472B Oviductus ranae soft capsule manufacturing process |
| 01/12/2011 | CN101439040B Medical use of 2-O-alpha-L-rhamnose-4,6,4'-trihydroxybenzophenone |
| 01/12/2011 | CN101406677B Medicinal liquor having function for warming and invigorating kidney yang |
| 01/11/2011 | US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders |
| 01/11/2011 | US7868002 Deazapurines and uses thereof |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867480 Non-invasive vaccination through the skin |
| 01/11/2011 | US7867475 Using NK gene complex family of type II oligomeric signal transmitting receptor proteins containing C-type lectin-binding domain; increasing tumor necrosis factor alpha production; autoimmune diseases |